American Society of Hematology--48th Annual Meeting and Exposition. Updates on hematological therapies. 9-12 December 2006 Orlando, FL, USA.
Walker
Karen
K
Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE UK. karen.walker@thomson.com
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols; D016227:Benzoquinones / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006405:Hematology / Q000639:trends*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors; D047029:Lactams, Macrocyclic / Q000627:therapeutic use; D009196:Myeloproliferative Disorders / Q000188:drug therapy; D010767:Phosphorylcholine / Q000031:analogs & derivatives / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use
D000970:Antineoplastic Agents; D016227:Benzoquinones; D001897:Boronic Acids; D007211:Indoles; D047029:Lactams, Macrocyclic; D011719:Pyrazines; C499748:SCIO-469; D010767:Phosphorylcholine; C105905:perifosine; C112765:tanespimycin; D000069286:Bortezomib; D053614:Janus Kinase 2